Loading, please wait.
From the monthly archives: September, 2016
We are pleased to present below all posts archived in 'September, 2016'. If you still can't find what you are looking for, try using the search box.
The British In Vitro Diagnostics Association represents the IVD Industry in the UK, to Government, professional bodies, the public, and at the European Diagnostic Manufacturers Association. BIVDA promotes the clinical and cost utility of IVDs in the provision of effective healthcare, both in acute diagnosis and in the prediction and prevention of disease.
Read the rest of entry »
Labsystems Diagnostics has been a pioneer in diagnostic development for 30 years. The company develops, manufactures and markets high quality enzyme immunoassays (EIA and FEIA) and rapid Point of Care (POC) tests globally for clinical laboratory use, home use and doctors offices.
As a result of the new distribution agreement, Oxford Biosystems will represent Labsystems Diagnostics in the UK and the Republic of Ireland. The Labsystems products for infectious diseases and gastrointestinal disorders will complement the existing Oxford Biosystems product range extremely well. As a pioneer in Newborn Screening (NBS) Labsystems have a range of high quality products and instrumentation that we are looking forward to introducing to our customers.
www.labsystemsdx.com
FGF2-STAB is a stabilised growth factor that offers a novel way to grow FGF2-dependant cell cultures more efficiently with fewer media changes. FGF2-STAB retains full biological activity even after 5 days at 37°C. This stability allows for a more homogenous, undifferentiated stem cell culture, while saving researchers valuable time and money because repeated supplementation of FGF2 and daily media changes are not required.
Read the rest of entry »
